Short Interest in MDB Capital Holdings, LLC (NASDAQ:MDBH) Grows By 463.4%

MDB Capital Holdings, LLC (NASDAQ:MDBH) was the target of a large increase in short interest in March. As of March 13th, there was short interest totaling 6,192 shares, an increase of 463.4% from the February 26th total of 1,099 shares. Approximately 0.1% of the company’s stock are sold short. Based on an average daily volume of 8,191 shares, the short-interest ratio is presently 0.8 days. Based on an average daily volume of 8,191 shares, the short-interest ratio is presently 0.8 days. Approximately 0.1% of the company’s stock are sold short.

MDB Capital Stock Performance

Shares of MDBH stock traded up $0.04 during trading hours on Wednesday, reaching $2.99. The company had a trading volume of 5,299 shares, compared to its average volume of 5,974. The business has a fifty day moving average price of $3.16 and a 200-day moving average price of $3.42. MDB Capital has a one year low of $2.75 and a one year high of $6.52. The firm has a market cap of $30.27 million, a PE ratio of 3.21 and a beta of 1.05.

Analysts Set New Price Targets

Separately, Weiss Ratings reaffirmed a “sell (d)” rating on shares of MDB Capital in a report on Thursday, January 22nd. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company presently has an average rating of “Sell”.

Institutional Investors Weigh In On MDB Capital

Large investors have recently added to or reduced their stakes in the stock. DRW Securities LLC purchased a new stake in MDB Capital during the 4th quarter valued at $40,000. Citadel Advisors LLC purchased a new position in shares of MDB Capital in the 3rd quarter worth $43,000. Finally, Raymond James Financial Inc. bought a new stake in shares of MDB Capital in the second quarter worth $27,000. Institutional investors own 0.35% of the company’s stock.

MDB Capital Company Profile

MDB Capital Holdings, LLC, through its subsidiaries, primarily operates as a broker-dealer. The company operates through two segments, Broker Dealer & Intellectual Property Service, and Technology Development. The Broker Dealer & Intellectual Property Service segment operates as a full-service broker dealer that focuses on conducting private and public securities offerings, as well as providing research services for investment banking due diligence. The Technology Development segment engages in the synthetic biology technology development business.